| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VIROL.2017.12.032 |
| P698 | PubMed publication ID | 29304471 |
| P50 | author | Julie Ledgerwood | Q23303181 |
| Theodore C Pierson | Q59939112 | ||
| Leslie Goo | Q66680234 | ||
| Barney S. Graham | Q89108863 | ||
| Richard Kuhn | Q56451214 | ||
| P2093 | author name string | Christina R DeMaso | |
| Rebecca S Pelc | |||
| P2860 | cites work | Probable non-vector-borne transmission of Zika virus, Colorado, USA | Q22240615 |
| Zika Virus Outbreak, Bahia, Brazil | Q22330702 | ||
| Detection of Zika virus in saliva | Q22330713 | ||
| Detection of Zika virus in urine | Q22330729 | ||
| Zika Virus Infection in Pregnant Women in Rio de Janeiro — Preliminary Report | Q23005539 | ||
| Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study | Q23012849 | ||
| Mechanism and significance of cell type-dependent neutralization of flaviviruses | Q23032973 | ||
| The 3.8 Å resolution cryo-EM structure of Zika virus | Q23680595 | ||
| Detection of Zika Virus in Semen | Q24048084 | ||
| Structure of the thermally stable Zika virus | Q24082710 | ||
| Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study | Q24255260 | ||
| Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere | Q24261248 | ||
| Zika virus: History, emergence, biology, and prospects for control | Q24261421 | ||
| An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014 | Q24574380 | ||
| The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry | Q24620686 | ||
| The global distribution and burden of dengue | Q24628768 | ||
| Structure of dengue virus: implications for flavivirus organization, maturation, and fusion | Q24736810 | ||
| Structural basis of potent Zika–dengue virus antibody cross-neutralization | Q24740325 | ||
| Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype | Q26252060 | ||
| Degrees of maturity: the complex structure and biology of flaviviruses | Q26824712 | ||
| Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains | Q27469847 | ||
| West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection | Q27472821 | ||
| Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus | Q27473186 | ||
| Structures of immature flavivirus particles | Q27477478 | ||
| Structure of Immature West Nile Virus | Q27480359 | ||
| Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization | Q27485890 | ||
| The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection | Q27488224 | ||
| Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody | Q27490283 | ||
| The flavivirus precursor membrane-envelope protein complex: structure and maturation | Q27650164 | ||
| Structure of the immature dengue virus at low pH primes proteolytic maturation | Q27650165 | ||
| Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity | Q27654848 | ||
| Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope | Q27674417 | ||
| Cryo-EM structure of the mature dengue virus at 3.5-Å resolution | Q27675507 | ||
| Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 | Q27678306 | ||
| The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution | Q27730234 | ||
| Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy | Q28005781 | ||
| Structure of the immature Zika virus at 9 Å resolution | Q28223583 | ||
| A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis | Q28804076 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target | Q29547347 | ||
| Structure of West Nile Virus | Q29618173 | ||
| The outbreak of West Nile virus infection in the New York City area in 1999 | Q29618175 | ||
| Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM | Q29618178 | ||
| Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines | Q33924834 | ||
| A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus | Q33954392 | ||
| Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition | Q34261496 | ||
| Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity | Q35101464 | ||
| A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus | Q35654743 | ||
| Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing | Q36245225 | ||
| Vaccination Against Dengue: Challenges and Current Developments | Q38620005 | ||
| Zika Virus: Immunity and Vaccine Development | Q38969772 | ||
| Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice | Q40052932 | ||
| Structural Basis of Zika Virus-Specific Antibody Protection | Q40056291 | ||
| A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection | Q40344161 | ||
| The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin). | Q40469073 | ||
| The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein | Q42980684 | ||
| Field effectiveness of vaccination against tick-borne encephalitis | Q43040713 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Zika virus | Q202864 |
| virion | Q1757347 | ||
| P1104 | number of pages | 12 | |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P304 | page(s) | 191-202 | |
| P577 | publication date | 2018-01-02 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | The Zika virus envelope protein glycan loop regulates virion antigenicity | |
| P478 | volume | 515 |
| Q93017534 | A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization |
| Q84957921 | A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein |
| Q60031636 | An Evolutionary Insight into Zika Virus Strains Isolated in the Latin American Region |
| Q56341896 | An Update on Sexual Transmission of Zika Virus |
| Q58784010 | Early Events in Japanese Encephalitis Virus Infection: Viral Entry |
| Q63248501 | Envelope protein glycosylation mediates Zika virus pathogenesis |
| Q90244931 | Flavivirus envelope protein glycosylation: impacts on viral infection and pathogenesis |
| Q63248442 | Human antibody response to Zika targets type-specific quaternary structure epitopes |
| Q91757156 | Multiscale analysis for patterns of Zika virus genotype emergence, spread, and consequence |
| Q49791115 | N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut Invasion by Flaviviruses |
| Q54221789 | Probing Molecular Insights into Zika Virus⁻Host Interactions. |
| Q56348817 | Probing Zika virus neutralization determinants with glycoprotein mutants bearing linear epitope insertions |
| Q99731978 | Protective and enhancing interactions among dengue viruses 1-4 and Zika virus |
| Q51782806 | Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice. |
| Q56341947 | Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development |
| Q59350859 | Structural disorder in the proteome and interactome of Alkhurma virus (ALKV) |
| Q58742686 | Zika Virus Vaccines: Challenges and Perspectives |
Search more.